Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsebeth Lynge

Showing results (111-120 of 303) with videos related to

Pageof 31
Sort By:
Journal of Clinical Microbiology|August 19, 2016
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial AssaysMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Cancer Epidemiology|January 23, 2014
Predictors of non-participation in cervical screening in DenmarkJenny Hansen Kristensson, Bente Braad Sander, My von Euler-Chelpin, et al.
BMC Public Health|July 29, 2024
Non-participation in breast screening in Denmark: Sociodemographic determinantsMy von Euler-Chelpin, George Napolitano, Elsebeth Lynge, et al.
BMJ (Clinical Research Ed.)|August 5, 2003
European Commission's proposal for a council recommendation on cancer screeningMarc Arbyn, Herman Van Oyen, Elsebeth Lynge, et al.
Breast Cancer Research and Treatment|June 24, 2020
Hormone replacement therapy and mammographic density: a systematic literature reviewShadi Azam, Katja Kemp Jacobsen, Arja R Aro, et al.
International Journal of Cancer|May 5, 2017
Benefit-to-harm ratio of the Danish breast cancer screening programmeAnna-Belle Beau, Elsebeth Lynge, Sisse Helle Njor, et al.
BMC Infectious Diseases|July 28, 2014
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray systemJesper Bonde, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMC Cancer|July 22, 2016
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySarah Preisler, Matejka Rebolj, Ditte Møller Ejegod, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 17, 2006
Do changes in lymph node status distribution explain trends in survival of breast cancer patients in Denmark?Klaus Rostgaard, Michael Vaeth, Helle Rootzén, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2013
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assayMatejka Rebolj, Sarah Preisler, Ditte M Ejegod, et al.
Pageof 31

Showing results (111-120 of 303) with videos related to

Sort By:
Pageof 31
Journal of Clinical Microbiology|August 19, 2016
Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial AssaysMatejka Rebolj, Jesper Bonde, Sarah Preisler, et al.
Cancer Epidemiology|January 23, 2014
Predictors of non-participation in cervical screening in DenmarkJenny Hansen Kristensson, Bente Braad Sander, My von Euler-Chelpin, et al.
BMC Public Health|July 29, 2024
Non-participation in breast screening in Denmark: Sociodemographic determinantsMy von Euler-Chelpin, George Napolitano, Elsebeth Lynge, et al.
BMJ (Clinical Research Ed.)|August 5, 2003
European Commission's proposal for a council recommendation on cancer screeningMarc Arbyn, Herman Van Oyen, Elsebeth Lynge, et al.
Breast Cancer Research and Treatment|June 24, 2020
Hormone replacement therapy and mammographic density: a systematic literature reviewShadi Azam, Katja Kemp Jacobsen, Arja R Aro, et al.
International Journal of Cancer|May 5, 2017
Benefit-to-harm ratio of the Danish breast cancer screening programmeAnna-Belle Beau, Elsebeth Lynge, Sisse Helle Njor, et al.
BMC Infectious Diseases|July 28, 2014
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray systemJesper Bonde, Matejka Rebolj, Ditte Møller Ejegod, et al.
BMC Cancer|July 22, 2016
Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample studySarah Preisler, Matejka Rebolj, Ditte Møller Ejegod, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 17, 2006
Do changes in lymph node status distribution explain trends in survival of breast cancer patients in Denmark?Klaus Rostgaard, Michael Vaeth, Helle Rootzén, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2013
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assayMatejka Rebolj, Sarah Preisler, Ditte M Ejegod, et al.
Pageof 31